Illya Keith Maher - Net Worth and Insider Trading

Illya Keith Maher Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Illya Keith Maher owns 5 companies in total, including Tenax Therapeutics Inc (TENX) , Tetraphase Pharmaceuticals Inc (TTPH) , and Kiora Pharmaceuticals Inc (KPRX) among others .

Click here to see the complete history of Illya Keith Maher’s form 4 insider trades.

Insider Ownership Summary of Illya Keith Maher

Ticker	Comapny	Transaction Date	Type of Owner
TENX	Tenax Therapeutics Inc	2020-07-20	director
TTPH	Tetraphase Pharmaceuticals Inc	2020-01-22	director
KPRX	Kiora Pharmaceuticals Inc	2020-01-10	director
		2019-10-25	director
		2021-10-15	director

Illya Keith Maher Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Illya Keith Maher Ownership Network

Ownership Network List of Illya Keith Maher

No Data

Ownership Network Relation of Illya Keith Maher

Illya Keith Maher Owned Company Details

What does Tenax Therapeutics Inc do?

Who are the key executives at Tenax Therapeutics Inc?

Illya Keith Maher is the director of Tenax Therapeutics Inc. Other key executives at Tenax Therapeutics Inc include Interim CFO Eliot M Lurier , director & CEO Chrisopher Thomas Giordano , and Chief Medical Officer Stuart Rich .

Tenax Therapeutics Inc (TENX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tenax Therapeutics Inc (TENX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tenax Therapeutics Inc (TENX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tenax Therapeutics Inc (TENX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tenax Therapeutics Inc Insider Transactions

No Available Data

What does Tetraphase Pharmaceuticals Inc do?

Who are the key executives at Tetraphase Pharmaceuticals Inc?

Illya Keith Maher is the director of Tetraphase Pharmaceuticals Inc. Other key executives at Tetraphase Pharmaceuticals Inc include director & See Remarks Larry G. Edwards , director & 10 percent owner Steven Boyd , and director & 10 percent owner Armistice Capital Master Fund Ltd. .

Tetraphase Pharmaceuticals Inc (TTPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tetraphase Pharmaceuticals Inc (TTPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tetraphase Pharmaceuticals Inc Insider Transactions

No Available Data

What does Kiora Pharmaceuticals Inc do?

Who are the key executives at Kiora Pharmaceuticals Inc?

Illya Keith Maher is the director of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Interim CFO Susan L. Drexler , and director & President and CEO Brian M. Strem .

Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kiora Pharmaceuticals Inc Insider Transactions

No Available Data

What does Vaxart Inc do?

Who are the key executives at Vaxart Inc?

Illya Keith Maher is the director of Vaxart Inc. Other key executives at Vaxart Inc include Chief Financial Officer Phillip E Lee , Interim CFO Fuad Ahmad , and SVP & General Counsel Edward B Berg .

Vaxart Inc (VXRT) Insider Trades Summary

Over the past 18 months, Illya Keith Maher made no insider transaction in Vaxart Inc (VXRT). Other recent insider transactions involving Vaxart Inc (VXRT) include a net purchase of 20,000 shares made by W. Mark Watson ,

In summary, during the past 3 months, insiders sold 0 shares of Vaxart Inc (VXRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vaxart Inc (VXRT) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 20,000 shares.

Vaxart Inc (VXRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vaxart Inc Insider Transactions

No Available Data

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Illya Keith Maher is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Illya Keith Maher made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 6,083 shares made by Garry Arthur Neil .

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avalo Therapeutics Inc Insider Transactions

No Available Data

Illya Keith Maher Mailing Address

Above is the net worth, insider trading, and ownership report for Illya Keith Maher. You might contact Illya Keith Maher via mailing address: C/o Armistice Capital, 510 Madison Ave., 7th Floor, New York Ny 10022.

Discussions on Illya Keith Maher

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.